Deep Sleep, Daytime Control Key to Nocturnal Enuresis Management
By Elana Gotkine HealthDay Reporter

MONDAY, June 23, 2025 -- Specific factors, including deep sleep and daytime urinary control, are associated with treatment-responsive nocturnal enuresis among children, according to a study published online April 23 in BMC Pediatrics.
Parsa Lorestani, from the Kermanshah University of Medical Sciences in Iran, and colleagues conducted a cross-sectional study involving 144 children aged 5 to 8 years with nocturnal enuresis: 85 treatment-controlled and 59 treatment-resistant. Participants received desmopressin nasal spray. Multifaceted factors underlying different treatment outcomes were examined.
The researchers found that abnormal residual urine volume, one episode of bedwetting per night, and more than one episode of bedwetting per night were significantly different between the groups. Factors that were more common in the treatment-responsive group included deep sleep and daytime urinary control (85.9 and 77.6 percent, respectively). Higher rates of poor medication adherence and high urine volume per episode were seen for treatment-resistant children (94.9 and 86.4 percent, respectively), although these parameters were not statistically significant.
"These findings underscore the importance of individualized management strategies that address specific clinical and behavioral factors in treatment-resistant cases, potentially improving therapeutic outcomes," the authors write. "Longitudinal research is needed to assess long-term treatment efficacy and explore new therapeutic approaches, with a focus on improving outcomes for children with nocturnal enuresis."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-24 06:00
Read more

- Weed Use Linked To Heart-Related Deaths
- Novo Nordisk to Advance Subcutaneous and Oral Amycretin for Weight Management Into Phase 3 Clinical Development
- FDA Approves Zusduri (mitomycin) for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
- Texas Invests $50M in Psychedelic Drug Research into Ibogaine to Treat Addiction
- Genetic Tests For Autism, Intellectual Disability Not Being Done On Medicaid Kids
- Electronic Nudge Letters Do Not Improve Guideline-Directed Medical Therapy in CKD
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions